Physician profile
Brian Eric Jaynes
NPI 1306078845
$1,162.24
in general payments reported to CMS, 2019-2025
8 companies · $63.29 in 2025
The $63.29 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $835 · 2020: $15.77 · 2021: $14.75 · 2022: $14.81 · 2023: $180 · 2024: $38.78 · 2025: $63.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivoclar Vivadent, INC. | $731.55 | 2019 | |
| Dentsply Sirona INC | $277.88 | 2019-2023 | Suresmile, Cavitron, Implant Dentistry |
| Patterson Companies, INC. | $87.69 | 2024-2025 | |
| Peter Brasseler Holdings, LLC | $14.81 | 2022 | |
| Solventum Corporation | $14.38 | 2024 | 3m Scotchbond, 3m Relyx, 3m Espe Filtek Supreme Ultra Universal Restorative |
| 3m Company | $13.62 | 2023 | Scotchbond Universal, 3m Relyx, 3m Filtek |
| Orapharma, A Division of Bausch Health US, LLC | $11.25 | 2019 | |
| Philips North America LLC | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Jaynes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.